ProShare Advisors LLC grew its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD – Free Report) by 28.6% in the 4th quarter, Holdings Channel.com reports. The fund owned 4,683 shares of the medical instruments supplier’s stock after acquiring an additional 1,041 shares during the period. ProShare Advisors LLC’s holdings in Mettler-Toledo International were worth $6,529,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Principal Financial Group Inc. increased its holdings in shares of Mettler-Toledo International by 2.9% during the third quarter. Principal Financial Group Inc. now owns 298,429 shares of the medical instruments supplier’s stock valued at $366,354,000 after acquiring an additional 8,360 shares in the last quarter. Nordea Investment Management AB increased its holdings in shares of Mettler-Toledo International by 11.9% during the fourth quarter. Nordea Investment Management AB now owns 157,457 shares of the medical instruments supplier’s stock valued at $220,718,000 after acquiring an additional 16,777 shares in the last quarter. Machina Capital S.A.S. bought a new position in shares of Mettler-Toledo International during the third quarter valued at $1,186,000. Citigroup Inc. increased its holdings in shares of Mettler-Toledo International by 4.8% during the third quarter. Citigroup Inc. now owns 65,033 shares of the medical instruments supplier’s stock valued at $79,835,000 after acquiring an additional 2,989 shares in the last quarter. Finally, AustralianSuper Pty Ltd increased its holdings in shares of Mettler-Toledo International by 7.0% during the third quarter. AustralianSuper Pty Ltd now owns 126,734 shares of the medical instruments supplier’s stock valued at $155,580,000 after acquiring an additional 8,333 shares in the last quarter. 95.07% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
Several equities analysts have recently weighed in on MTD shares. Morgan Stanley reduced their price target on Mettler-Toledo International from $1,475.00 to $1,275.00 and set an “equal weight” rating for the company in a report on Tuesday, May 12th. Stifel Nicolaus reduced their price target on Mettler-Toledo International from $1,600.00 to $1,400.00 and set a “buy” rating for the company in a report on Monday, May 18th. Robert W. Baird reduced their price target on Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating for the company in a report on Monday, May 11th. Citigroup reduced their price objective on Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating for the company in a report on Friday, May 8th. Finally, JPMorgan Chase & Co. reduced their price objective on Mettler-Toledo International from $1,413.00 to $1,200.00 and set a “neutral” rating for the company in a report on Monday, May 11th. Six research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $1,408.55.
Mettler-Toledo International Stock Performance
NYSE MTD opened at $1,104.63 on Friday. Mettler-Toledo International, Inc. has a one year low of $1,023.05 and a one year high of $1,525.17. The stock has a 50-day moving average of $1,227.48 and a 200 day moving average of $1,342.55. The company has a market capitalization of $22.32 billion, a price-to-earnings ratio of 25.91, a PEG ratio of 2.27 and a beta of 1.31.
Mettler-Toledo International (NYSE:MTD – Get Free Report) last released its quarterly earnings data on Thursday, May 7th. The medical instruments supplier reported $8.91 EPS for the quarter, topping the consensus estimate of $8.70 by $0.21. Mettler-Toledo International had a negative return on equity of 622.80% and a net margin of 21.40%.The company had revenue of $947.13 million during the quarter, compared to the consensus estimate of $943.14 million. During the same period last year, the company earned $8.19 EPS. Mettler-Toledo International’s revenue for the quarter was up 7.2% on a year-over-year basis. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. On average, equities analysts predict that Mettler-Toledo International, Inc. will post 46.6 earnings per share for the current fiscal year.
Mettler-Toledo International Company Profile
Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.
The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.
Read More
- Five stocks we like better than Mettler-Toledo International
- SpaceX IPO: Opportunity? Or the Ultimate Hype Trade?
- CAVA Group’s Stock Looks Delicious After Strong Earnings
- Lowe’s Finds Support at $215 After Q1 Earnings Sell-Off
- Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook
Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International, Inc. (NYSE:MTD – Free Report).
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.
